Shivaani Kummar appointed interim Chief Executive of the Knight Cancer Institute
March 20, 2025
Kummar will serve until OHSU's new president is able to recruit a permanent leader for the institute.
Ensayo clínico da resultados prometedores para estimular más pruebas de detección de cáncer colorrectal en áreas rurales
March 17, 2025
Con más de 5,600 personas inscritas en áreas rurales de Oregón, el estudio aborda los índices de detección bajos.
Clinical trial shows promising results for boosting colorectal cancer screening in rural areas
March 17, 2025
With more than 5,600 Medicaid enrollees in rural Oregon, the study addresses low screening rates.
Se confirma en un estudio de OHSU el vínculo entre la densidad mamaria y mayor riesgo de cáncer de mama
March 10, 2025
El riesgo de desarrollar cáncer de mama es 1.7 veces mayor para mujeres con mamas densas.
OHSU study confirms link between breast density, higher breast cancer risk
March 10, 2025
Risk of developing breast cancer is 1.7 times higher for women with dense breasts.
Carolanne Wipfli named Vice President of Development for the OHSU Foundation
February 27, 2025
Carolanne Wipfli has been named vice president of development at the OHSU Foundation, after having served in an interim role since the spring of 2024.
OHSU scientists develop first transgenic model for hepatitis B research
February 12, 2025
The genetically modified animal model could lead to new treatments for the global disease.
New blood test identifies hard-to-detect pancreatic cancer with 85% accuracy
February 12, 2025
Called PAC-MANN, the test developed at OHSU could help save lives.
Prueba de sangre nueva identifica cáncer pancreático difícil de detectar con 85% de precisión
February 12, 2025
Llamada PAC-MANN, la prueba desarrollada en OHSU puede ayudar a salvar vidas.